Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Accumulated Expenses (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Accumulated Expenses for 10 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 1.4% to $13.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.7 million, a 1.4% decrease, with the full-year FY2025 number at $13.7 million, down 1.4% from a year prior.
  • Accumulated Expenses was $13.7 million for Q4 2025 at Orthopediatrics, down from $13.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $13.9 million in Q4 2024 to a low of $4.4 million in Q1 2022.
  • A 5-year average of $9.0 million and a median of $8.4 million in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: dropped 8.6% in 2022, then skyrocketed 67.93% in 2023.
  • Orthopediatrics' Accumulated Expenses stood at $5.4 million in 2021, then grew by 26.03% to $6.7 million in 2022, then soared by 67.93% to $11.3 million in 2023, then grew by 22.63% to $13.9 million in 2024, then fell by 1.4% to $13.7 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Accumulated Expenses are $13.7 million (Q4 2025), $13.8 million (Q3 2025), and $13.4 million (Q2 2025).